Furthermore, therapeutic targeting of Twist could inhibit TGF-β-induced upregulation of Wnt3 and enhance the sensitivity of chemo and target therapies, and subsequently could prevent tumor metastases caused by TGF-β. This evidence concerns the gene TGFB1 and neoplasm.